I guess my point was, I'm not arguing that every drug should be covered. If I'm saying everybody doesn't have access, I'm merely suggesting the evidence doesn't suggest that the drug has a significant enough impact on quality or quantity of life, or that the cost is such that it doesn't warrant reimbursement. That decision is being made, and not necessarily by a bureaucrat. I think we have multiple contributors to that decision-making process. It means everybody has the same access whether it be access to the drug, or maybe no access to a drug that we shouldn't have access to.
